VTI Announces Positive Interim 1-Year Data from the PROTECT Clinical Trial at American Academy of Optometry Annual Meeting

Contributed by: Business Wire

Logo

Tags

Medical Supplies

Health

Medical Devices

Consumer

Children

Clinical Trials

Optical

Visioneering Technologies, Inc.

More Like This

PR Newswire associated0

HOYA Vision Care Releases One-Year MiYOSMART European Study Results

PR Newswire associated0

New Ipsos global survey shines a light on the myopia epidemic

Evolution Optiks Expands IP Portfolio with Two Key U.S. Patents for Light Field Powered Tele-Refractor

LumiThera’s LIGHTSITE IIIB Extension Trial Topline Results Show Extended Vision Improvement in Dry AMD Subjects

PR Newswire associated0

Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma

Evolution Optiks Successfully Completes Data Collection in Clinical Study of Neuro-Optical Testing Device

Evolution Optiks Receives U.S. FDA 510(k) Clearance for Breakthrough Eye Examination Device